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BACKGROUND: During the last decade, epidemiological studies uncovered the tremendous impact of metabolic syndrome/diabetes
mellitus type 2 (DM T2) as risk factors of the progression of cancer. Therefore, we studied the impact of diabetogenic glucose
and insulin concentrations on the activities of tumour cells, because little is known about how high glucose and insulin levels are
influencing gene activities causing changes in the signal cascade activities with respect to kinases involved in the proliferation and
migration of cancer cells.
METHODS: To address this question we analysed the activity of more than 400 gene signatures related to (i) cell cycle, (ii) cell
movement as well as (iii) signal transduction. We examined transcriptoms of kinases (PKCa, PI3K), cadherins (E-, N- VE-), integrins
and cyclins by comparing physiological (5.5mM) vs diabetogenic (11mM) glucose concentrations (without and with insulin).
RESULTS: Proliferation assays revealed that high levels of glucose (11mM) and insulin (100ngml
 1) did promote the proliferation of the
tumour cell lines HT29, SW480, MCF-7, MDA MB468, PC3 and T24. Using a 3D-migration assay, we have shown that high glucose
concentrations caused increased motility rates of the tumour cells. The increase in migratory activity at high glucose and insulin
concentrations was mediated by an activation of PI3K, PKCa and MLCK, as figured out by the pharmacological inhibitors wortmannin,
Go6976 and ML-7.
CONCLUSION: We present molecular and functional data, which could help to understand how hyperglycaemia and hyperinsulinemia
might trigger tumour cell proliferation and motility in patients, too.
British Journal of Cancer (2011) 104, 345–352. doi:10.1038/sj.bjc.6606050 www.bjcancer.com
Published online 21 December 2010
& 2011 Cancer Research UK
Keywords: hyperglycaemia; hyperinsulinemia; Warburg effect; proliferation; adhesion; cell migration
                                                   
Over the past few decades the number of people with excess body
weight has been increasing in both industrialised and developing
countries. About 50% of men and 35% of women in Europe are
currently estimated to be overweight or obese. Bianchini et al
(2002) showed that excess body weight is directly associated with
risk of cancer at several organ sites, including colon and breast.
Latest epidemiological studies indicated a connection between
obesity/diabetes mellitus type II (DM T2) and increased appear-
ance of new tumour cases. Adiposity is leading to increased serum
glucose, insulin and triglycerides levels, which are risk factors
for cardiovascular disease and DM T2. Retrospective (Krone and
Ely, 2005) and prospective (Stattin et al, 2007) studies indicating
a direct influence of high glucose and triglycerides on the
progression of cancer. The outcome, if these epidemiological data
is that metabolic alterations leading to obesity, insulin resistance
and adiposity are not only risk factors to get DM T2 but also risk
factors for various kinds of cancer (Giovannucci, 2001; Keku et al,
2005). There is growing evidence that the metabolic syndrome is
a common nominator for hypertension, DM T2 and some types of
cancer (Brauer et al, 2002; Vona-Davis et al, 2007).
Besides an increasing number of epidemiological investigations,
there are less experimental studies investigating the molecular
background between metabolic alterations and the progression of
cancer (Yin et al, 2005; Langbein et al, 2006). Nevertheless,
since more than two decades it is known that glucose is the driving
force for the growth of tumour cells (Beckner et al, 1990) and that
increased insulin levels promote metastasis (Stracke et al, 1988).
However, little is known about the effects of increased glucose and
insulin concentrations on changes at the transcriptom level or on
the modulation of signalling cascades involved in cell motility or
adhesion. Recent in vitro studies suggest that an important
mechanism of enhanced glucose metabolism in carcinoma cells
involves the overexpression of transmembrane glucose transpor-
ters (Rudlowski et al, 2004; Hauptmann et al, 2005). Changes in
glucose metabolism have also been found in many tumours,
causing an increased production of lactate (Walenta et al, 2000;
Walenta and Mueller-Klieser, 2004). Elevated lactate within cancer
cells indicates a switch in glucose metabolism from aerobe to an
anaerobe utilisation of glucose, first described by Warburg (1956).
Modern molecular biology leads to a renaissance of the Warburg
effect (Kim and Dang, 2006; Kondoh, 2008). A permanent increase
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sof anaerobe glucose utilisation in primary tumours characterizes
more aggressive tumour cells (Walenta et al, 2001). The reduced
mitochondrial respiration and an increased conversion of
glucose into lactate combined with an enhanced secretion of
lactate is associated with an acidification of the tumour and its
environment (Pelicano et al, 2006). This turns into an advantage
for tumour cells with a resistance to acidosis, realized by
an increased H
þ transporter activity (e.g. N
þ/H
þ exchanger)
(Gatenby et al, 2007). However, in non-malignant tissues, an acidic
microenvironment is ordinarily toxic to mammalian cells typically
resulting in apoptosis through activation of caspases (Thews et al,
2007). The persistence of acidosis is leading to the destruction of
the extra cellular matrix surrounding the tumour – possibly
further supported by the acid-mediated activation of matrix
metalloproteinases (Chaussain-Miller et al, 2006), and thereby
promoting migration of tumour cells, a prerequisite of metastasis
formation (Langbein et al, 2006).
Here, we report about changes in proliferation, locomotion and
gene signatures of tumour cells cultured under diabetogenic
conditions when compared with physiological glucose concentra-
tions. Moreover, the addition of insulin to hyperglycemic-grown
tumour cells further increased proliferation, as well as cell
migration, by modifying the expression of molecules involved in
cell cycle regulation, signal transduction, cell–cell adhesion and
cellular locomotion.
MATERIALS AND METHODS
Cell culture and treatment
All cell lines were cultured at three different conditions in parallel:
RPMI1640 either containing 5.5mM or 11mM glucose, or RPMI
with 11mM glucose plus 100ngml
 1 insulin. Each medium was
supplemented with 10% FBS, 1% penicillin/streptomycin, and cells
were kept at 371C in a humidified atmosphere (5% CO2). After an
adaptation of at least two passages at the appropriate media, cells
were used for experiments.
Three-dimensional cell migration assay
Cultured cells were harvested using a trypsin/EDTA solution and
100.000 cells were mixed with 150ml buffered liquid collagen
(pH 7.4, 1.63mgml
 1 collagen type I; Collagen Corporation,
Fremont, CA, USA) containing minimal essential medium (Sigma,
Deisenhofen, Germany) and the investigated substances: insulin,
wortmannin, ML-7 (Sigma) or Go6976 (Calbiochem, Bad Soden,
Germany), as described previously (Friedl et al, 1993). After
polymerization the chambers were sealed, and locomotion was
recorded by time-lapse video-microscopy 12h at 371C. For analysis
of the migratory activity, 30 cells per sample were randomly
selected, and projections of paths were digitised as x/y-coordinates
in 15-min intervals. The average migratory activity was calculated
for each 15-min interval (100% migratory activity is reached, when
all 30 cells migrate all over the time).
Proliferation assay
On day 0, 100.000 cells were seeded into 24-well plates and
incubated at physiological conditions (5.5mM), or at diabeto-
genic glucose concentrations (11mM) alone or in combination
with 100ngml
 1 insulin, respectively. Each day, two wells per
sample were trypsinized and counted to establish cell growth
curves. To determine proliferation rates, exponential phases
of each cell growth curve were used for calculations. A MTT
proliferation assay (CellTiter96 Aqueous One Solution Cell
Proliferation Assay/Promega, Madison, WI, USA) was performed
according to the manual, to confirm data received from cell growth
curves.
Gene activity/DNA microarray
Tumour cells were cultured at 5.5mM glucose, 11mM glucose or
11mM plus 100ngml
 1 insulin. Customised gene chips for DNA
microarray analysis were purchased from Ocimum Biosolutions
Ltd, Hyderabad, India. The mRNA (5mg) was prepared using a
Macherey & Nagel Nucleo Spin RNA 2 Kit (Macherey-Nagel Gmbh
&C oK G ,D u ¨ren, Germany), with a subsequent cDNA transcription.
Each Cy-3-labelled sample was combined with the Cy-5-labelled
control and hybridised onto customised Ocimum 40k arrays for 16h
at 651C. Hybridised arrays were scanned and quantified using the
Agilent Feature Extraction Software 7.1. (Agilent Technologies
Deutschland GmbH, Bo ¨blingen, Germany). Data were excluded for
genes that did not have an expression signal above 200 in either
channel. Significance was determined by an at least 2.5-fold change
in expression. Each experiment was repeated three times.
Immunoblotting
The expression levels of E-cadherin, MLCK and PKCa were
analysed by immunoblotting as described previously (Masur et al,
2001). Cells (2.5 E5 per sample) were lysed in Laemmli sample
buffer and incubated for 10min at 951C. Proteins were separated
using PAGE according to Laemmli (Laemmli, 1970) and were
transferred to an Immobilion-P membrane (Millipore, Bedford,
MA, USA), followed by blocking the membranes with 10% milk
powder (1h at RT). After incubating the membrane (over night at
41C) with the primary monoclonal antibodies against E-cadherin
(clone 67A4), purchased from Coulter-Immunotech (Krefeld,
Germany), the goat polyclonal antibody against MLCK (MYLK
(P-19): sc-22224; Santa Cruz Biotechnology Inc., Heidelberg,
Germany) or PKCa (Transduction Laboratories, Lexington, KY,
USA), membrane was washed vigorously with PBS-Tween.
Subsequently, the membrane was incubated with either anti-
mouse or anti-goat peroxidase-linked antibody (1h at RT),
followed by the chemiluminescence substrate (1min at RT) (Roche
Diagnostics, New Castle, IN, USA). Bands were visualised using
the BM chemiluminescence blotting substrate (Roche Diagnostics
GmbH, Mannheim, Germany) and detected by Aequoria
Macroscopic Imaging (Hamamatsu Photonics, Herrsching am
Ammersee, Germany).
Flow Cytometry
The expression of integrins and cadherins was analysed by flow
cytometry (antibodies see above). The IgG1 isotype and secondary FITC-
conjugated goat anti mouse or anti-rabbit antibody were obtained from
New England Biolabs, Frankfurt, Germany. The mean fluorescence
intensity of the bound antibody at 11mM glucose (±insulin) was
compared with the binding of the same antibody at 5.5mM.
PKC activity assay
The tumour cells (2.5 E5 per sample) were cultured either in
5.5mM,1 1 m M glucose or 11mM glucose plus 100ngml
 1 insulin,
and afterwards treated according to the manufacturer’s protocol
(StressXpress PKC Kinase Activity Assay Kit (EKS-420A), Biomol
GmbH, Hamburg, Germany). In brief, cells were lysed, centrifuged
and supernatants were added to PKC-substrate-coated wells. After
incubation with ATP, a phospho-specific HRP-conjugated antibody
was added, and finally TMB was used for colorimetric determina-
tion of PKC activity (Shirai and Saito, 2002). Absorbance of the
positive control was used to calculate the amount of active PKC.
Data analysis
Statistical comparison between specified values was made by
ANOVA using a Dunnett’s multiple comparisons test or the
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sstudent’s t-test. Significances are indicated by the stars: *Po0.05,
**Po0.01, ***Po0.001; NS, not significant (P40.05).
RESULTS
To analyse the proliferation capacity, we cultured tumour
cells lines of different organs (HT29 and SW480 colon carcinoma;
MCF-7 and MDA MB468 breast cancer; PC3 prostate cancer; T24
bladder carcinoma) at physiological and diabetogenic glucose
concentrations without and with the addition of 100ngml
 1
insulin (see Table 1A). Almost all tumour cell lines revealed higher
proliferation rates when cultured under hyperglycemic conditions,
and all cell lines showed increased proliferation after the addition
of 100ngml
 1 insulin. Although all cell lines displayed decreased
proliferation at low glucose concentrations of 2.75mM, there were
differences in the proliferation rate at physiological (5.5mM)
and diabetogenic glucose concentrations (11mM and 22mM).
HT29 and MCF-7 cells steadily increased the number of cells
when glucose concentration was elevated, whereas SW480 and T24
showed increased proliferation until a glucose concentration of
11mM, and at 22mM glucose proliferation dropped below the
11mM level. However, PC3 cells showed no significant differences
in proliferation in relation to glucose concentration. Furthermore,
all tumour cells grown in medium containing additional
100ngml
 1 of insulin (with 5.5mM or 11mM glucose) showed
a pronounced increase of proliferation – displaying on average
20–40 percent higher proliferation rates. Cell growth curves
revealed doubling times of 2.4 days for MDA MB468 cells when
cultured at normoglycemic conditions, 1.9 days at 11mM glucose
and 1.4 days when cultured in 11mM glucose plus 100ngml
 1
insulin (data not shown). Comparable results were found in SW480
colon carcinoma cells with 1.9 days at 5.5mM glucose vs 1.5 days at
11mM glucose and 1.4 days at 11mM plus 100ngml
 1 insulin.
Furthermore, also migratory activity was increased by high levels
of glucose and insulin. Table 1 displays the elevated migratory
activity (1B) and the increased distance migrated (1C) of the
investigated cancer cells. Both effects activity and distance were
strongly dependent on glucose concentrations. All cell lines
displayed an increased duration of migratory activity, resulting
in an enhanced distance of migration. Especially the shortening of
the pauses between periods of cell movement led to glucose- and
insulin-induced increases of migratory activity and therefore to
enhanced distances.
In MDA MB468 cells, we observed almost a doubling of the
distance migrated (18mm vs 33mm) comparing cells cultured in
5.5mM glucose or in 11mM glucose. At both glucose concen-
trations, addition of 100ngml
 1 insulin further increased the
distance migrated (36mm for 5.5mM plus insulin and 58mM
for 11mM plus insulin). Therefore, an increase of glucose- and
insulin concentration caused a three-fold elevated distance
migration of MDA MB468 cells. Both, glucose-mediated and
insulin-induced stimulation of locomotory activity could be
reduced with the PKCa-specific inhibitor Go6976 (6nM) to the
level of naı ¨ve cells.
DNA-microarray analysis revealed significant changes
(42.5-fold) in gene activity of numerous genes involved in
proliferation, adhesion and migration (Table 2). As shown in
Table 2, the most pronounced increase in gene activity was found
for cyclin A1: 14-fold increase at 5.5mM vs 11mM glucose. We also
found increased numbers on transcriptoms of genes involved in
signal transduction and locomotion (PKC alpha and delta,
integrins beta1 and alpha2 and several myosins). Interestingly,
genes for cell adhesion were differentially regulated. We found a
four-fold downregulation of E-cadherin on the one hand, but in
parallel a three-fold to five-fold upregulation of cadherins of the
vascular and neuronal subclass (Table 2) at diabetogenic glucose
and insulin concentrations.
Table 1 Glucose and insulin increase proliferation and migratory activity of different tumour cell lines
2.75mM 5.5mM 11mM 22mM 5.5mMþinsulin 11mMþinsulin
(A) Proliferation (%) in comparison to 5.5mM glucose
HT29 89.8* 100.0 113.4* 125.5** 110.2* 126.7**
SW480 92.4* 100.0 134.6** 129.4** 105.8 NS 144.2**
MDA MB468 84.1** 100.0 117.8* 118.8* 108.9* 133.7***
MCF-7 92.5* 100.0 108.6 NS 115.1* 104.3 NS 123.3**
PC3 97.3 NS 100.0 104.3 NS 106.6* 102.7 NS 107.0 NS
T24 95.3 NS 100.0 106.8 NS 93.8 NS 109.0 NS 107.5*
(b) Average migratory activity (%)
HT29 1.3 7.4 16.9 18.9 12.9 27.9
SW480 2.7 12.6 18.4 16.2 15.8 26.0
MDA MB468 6.8 9.6 14.4 17.4 12.3 24.6
MCF-7 5.5 18.8 23.5 19.2 24.0 29.4
PC3 12.2 12.0 17.3 16.3 17.9 37.5
T24 15.3 29.0 46.8 26.5 28.0 52.3
(C) Distance migrated (mm)
HT29 7.8 12.4 15.6 18.4 17.7 16.0
SW480 3.5 10.5 16.1 19.8 17.8 29.2
MDA MB468 8.6 17.8 32.8 27.0 35.5 57.5
MCF-7 2.4 7.6 8.2 7.3 10.8 14.1
PC3 10.9 12.6 16.9 15.9 13.0 15.4
T24 18.8 26.1 48.7 20.7 25.8 51.8
Abbreviation: NS¼not significant. *P40.05; **P40.01; ***P40.001. (A) End point determination of tumour cell proliferation after cultivation at either 5.5mM glucose, 11mM
glucose or 11mM glucose plus 100ngml
 1 insulin. (1E5 cells per sample were seeded and cultured for 1 week). All samples are compared with the physiological
glucose concentration of 5.5mM (100%). (B) Comparison of the average migratory activity of tumour cell lines revealed increased activity with increased glucose
levels (2.75mMo5.5mMo11mM), but also differences between the cell lines with regard to the ability to further increase activity at very high glucose concentrations (22mM).
(C) 3D-migration assays revealed up to three-fold increase in distance migrated (e.g. MDA MB468) cells were treated with high glucose (5.5mM vs 11mM) and insulin
(100ngml
 1) concentrations. The table show mean values of three independent experiments (90 cells were analyzed per sample). Statistical comparison between specified
values was made either by two-tailed unpaired t-test.
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sTo confirm these results at the protein level, we used flow
cytometry and western blot analysis, to determine the integrin and
cadherin protein expression levels (Figure 1). Figure 1A depicts
altered expression levels of alpha-2 integrin, beta-1 integrin,
E-cadherin, VE-cadherin and N-cadherin at physiological (5.5mM,
left column) glucose concentrations, high glucose concentrations
(11mM, middle column) and diabetogenic conditions (11mM plus
insulin, right column).
Using flow cytometry, we found an upregulation of alpha-2/
beta-1 integrins, the collagen receptor, when cells were cultured at
high glucose. Alpha-2/beta-1 integrin expression level was elevated
at diabetogenic condition (alpha-2 subunit: 1.2-fold and beta-1
subunit: 1.4-fold). When cells were cultured in high glucose and
high insulin concentration, the integrin expression was signi-
ficantly increased (alpha-2 integrin subunit: two-fold and beta-1
integrin subunit: 1.4-fold). This is in accordance with our results
found for the increased number of transcriptoms.
SW480 colon carcinoma cells express low levels of E-cadherin
on the cell surfaces, corresponding with a high migratory activity
(Masur et al, 2001). Although the DNA microarray data pointed
towards a diminished E-cadherin expression at diabetogenic
conditions, we were not able to confirm an additional reduction
of the constitutively low E-cadherin cell surface expression
(Figure 1A). For confirmation of the micro-array data, we also
performed western blot analysis to detect changes of the total
content of E-cadherin. Western blot analysis revealed a 30 and 25%
reduced protein-expression levels of E-cadherin in both, MDA
MB468 and SW480 cells, respectively (Figure 1B). Furthermore, we
found increased numbers of VE- and N-cadherin transcriptoms,
and also slightly increased VE- and N-cadherin cell surface levels,
comparing physiological and diabetogenic culture conditions.
In a first summary; altered levels of adhesion molecules did
promote locomotion of the investigated cell lines. The important
role of E-cadherin and PKCa in cell migration was already
described by Masur et al (Masur et al, 2001). Therefore, we
analysed signalling pathways of glucose and insulin leading to an
activation of PKCa and finally to an increased cellular motility.
Using the inhibitors wortmannin (PI3K inhibitor at 250nM),
Go6976 (PKCa inhibitor at 6nM) and ML-7 (MLCK inhibitor
at 10mM), we were able to track down the key molecules of the
signalling cascade of the glucose- and insulin-induced tumour cell
migration. Each of the three tested inhibitors showed a signi-
ficantly reduced migratory activity of the glucose mediated-,
the insulin-induced cell movement and also the combination
of high glucose and high insulin (Figure 2A). Thereby, not only
the percentage of moving cells was diminished by either
wortmannin, Go6976 or ML-7, also the distance migrated and
the duration of cellular movement were significantly reduced.
Wortmannin, for example, only reduced the insulin-mediated
increase of distance migrated down to control level of the
matching glucose concentration, whereas no significant further
reduction below the glucose-induced level could be observed
(Figure 2B). However, both Go6976 and ML-7 diminished the
insulin- and the glucose-mediated increase in tumour cell
migration. As both PKCa and MLCK seemed to have central roles,
we analysed the expression level of these key molecules by western
blot analysis.
The expression levels of PKCa were not significantly increased
when cells were cultured in hyperglycemic conditions (Figure 3A).
Therefore, it was consequent to study the enzymatic activity of
PKCs by measuring the phosphorylation of PKC substrates
(StressXpress PKC kinase activity kit). For specificity control,
we used the PKCa inhibitor Go6976. The PKC activity assay
revealed a 23% increased activity of the total classical PKC
enzymes in SW480 cells, comparing cells cultured at 11mM glucose
vs 5.5mM (Figure 3B). The classical PKC activity could be inhibited
by the PKCa inhibitor Go6976 at 6nM, independent of the
supplemented medium by glucose and insulin.
To further illuminate the major role of the classical PKCs
within the locomotory machinery, we stained the cells with the
PKC-specific dye rim-1 (Figure 4A–C). Although in resting
cells PKC staining/rim-1 is found in the cytosol (Figure 4A) and
PKC activation by glucose and insulin led to a translocation of
PKC to the membrane and into the pseudopodia (Figure 4B).
Incubating MDA MB468 cells with the PKCa-specific inhibitor
Go6976 prevented this translocation of PKC (Figure 4C).
As the DNA microarray data showed significant elevated levels
of non-muscle myosins and MLCK gene transcripts, we also
analysed the MLCK protein expression level. Western blot analysis
revealed a 30% increase of MLCK proteins in MDA MB468 cells at
hyperglycemic conditions when compared with physiological
conditions (Figure 5A). In SW480 cells, we found a more than 20
percent increase of MLCK expression. In addition, we performed
migration studies testing the influence of the MLCK-specific
inhibitor ML-7 (Figure 5B). High glucose (11mM) as well as high
glucose plus insulin (100ngml
 1) led to an elevated migratory
activity, resulting in an increased distance migrated. ML-7 at 10mM
was able to reduce both, the glucose-mediated as well as the
glucose- and insulin-mediated migratory activity of all tested
cell lines.
DISCUSSION
Epidemiological studies revealed a correlation between metabolic
alterations as found in people with obesity/adiposity and DM T2,
and an increased risk of cardiovascular diseases (Eckel et al, 2002;
Brown et al, 2008). These alterations found in obese people are
best summarised by the metabolic syndrome, mainly characterized
by high serum levels of glucose, insulin and triglycerides, as well as
a chaotic pattern of cytokines. However, Frezza et al and Stattin
Table 2 Micro array analysis revealed alterations of gene activity by
comparing physiological and diabetogenic conditions
5.5mM vs 11mM
glucose
5.5mM vs 11mM
glucoseþinsulin
Proliferation/cell cycle
Cyclin A1 14.09 11.13
Cyclin E2 4.90 2.39
E2F transcription factor 3 4.16 4.80
Signal transduction
Integrin-linked kinase 3.92 4.85
Phosphoinositide-3-kinase 2.76 4.05
Protein kinase Ca 4.68 9.71
Protein kinase Cd 4.55 5.01
MLCK 6.28 4.03
Cell migration and adhesion
Integrin b1 5.10 3.71
Integrin a2 5.66 4.89
Myosin IA 4.27 6.37
Myosin IE 4.44 8.35
Myosin VIIA 4.31 11.90
Nonmuscle myosin II 3.75 4.07
N-cadherin (neuronal) 3.79 6.35
VE-cadherin (vascular) 2.90 5.76
Matrix metallopeptidase 7 3.41 3.55
Matrix metallopeptidase 10 2.94 2.26
TIMP metallopeptidase inhibitor 3 0.40 0.33
E-cadherin (epithelial) 0.22 0.25
Tumour cell mRNA was transcripted into cDNA and labeled with either Cy3 or Cy5.
The activity of genes involved in cell migration/cell adhesion, in proliferation/cell cycle,
and in signal transduction was investigated. The DNA microarray analysis was
performed three times and only data with higher than 2.5-fold changes in gene
activity were taken into consideration.
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set al showed details on the influence of obesity on the progression
of cancer (Frezza et al, 2006; Stattin et al, 2007). However, there
are data from 20 years ago, describing the positive effects of
glucose and insulin on the progression of tumours (Stracke
et al, 1988; Beckner et al, 1990), without further identifying the
genetic and molecular modifications. Recently, we have compiled
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Figure 1 (A) Cell surface expression levels of a2a n db1 integrin, E-, N- and VE-cadherins on SW480 colon carcinoma cells. The antibody-bound FITC-
fluorescence of specific antibodies at 11mM glucose or 11mM glucose plus insulin (filled grey) was directly compared with 5.5mM control cells (grey line) as well as to
the isotype control (black line). Significant increases (more than 15%) have been found for a2, b1integrins and for VE-cadherin. For N-cadherin only a marginal
induction was detectable, whereas E-cadherin showed no significant changes. The geometric means (Gm) indicated the fluorescence intensity of the FITC-conjugated
antibodies. (B) Immunoblot analysis of E-cadherin expression of breast cancer (MDA MB468) and colon carcinoma (SW480) cell lines. Antibodies against the cell–
cell contact molecule E-cadherin were used, and specifically bound antibodies were detected with the use of a secondary HRP-linked mouse anti-human antibody.
The expression levels of all blots were evaluated using the Wasabi software version 1.4 (Hamamatsu Photonics, Herrsching am Ammersee, Germany).
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Figure 2 Analysis of the distance migrated of MDA MB468 breast cancer cells. Bars in (A) display the average distance (±s.e.m.) of 30 randomly
selected cells of a 12h observation period. Cells were cultured at either 5.5mM or 11mM glucose and treated with 100ngml
 1 insulin, 250nM wortmannin
or a combination of both substances. (B) Depicts the distance migrated and the average migratory activity of MDA MB468 cells cultured at either 5.5mM or
11mM glucose with and without additional insulin (100ngml
 1) and treated with the PI3K inhibitor wortmannin, the PKCa inhibitor Go6976, or the MLCK
inhibitor ML-7. The results show mean values of three independent experiments. Statistical comparison between specified values was made by two-tailed
unpaired t-test. *Po0.05; **Po0.01; ***Po0.001; NS, not significant.
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syndrome and diabetes mellitus on the progression of cancer
(Masur et al, 2008).
Established tumour cell lines are cultured routinely in media
containing high amounts of glucose, for example, RPMI1640
11mM, Mc Coy’s 5A 22mM and DMEM (high glucose) 25mM. This
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Figure 3 (A) Immunoblot analysis of PKCa expression of MDA MB468 breast cancer and SW480 colon carcinoma cell lines. Antibodies against
the human PKCa isotype were used, and specifically bound antibodies were detected with the use of a secondary HRP-linked mouse anti-human antibody.
The expression levels of all blots were evaluated using the Wasabi software version 1.4. (B) Analysis of the PKC kinase activity of SW480 colon carcinoma
cell lysates. Tumour cells were cultured at 5.5mM or 11mM glucose alone or in combination with 100ngml
 1 insulin. The PKCa-specific inhibitor Go6976
(6nM) was added to control and insulin-treated samples in parallel. The phosphorylation of the PKC substrate (coated on 96-well plates) was detected by an
HRP-conjugated secondary antibody, using a PKC kinase activity kit (StressXpress from Biomol). The graphs show mean values of three independent
experiments (2.5 E5 cells per sample). Statistical comparison between specified values was made either by two-tailed unpaired t-test or by ANOVA with
Dunnett’s multiple comparisons test. **Po0.01; ***Po0.001; NS, not significant.
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Figure 4 (A–C) PKC-specific dye rim-1 indicates that a translocation of PKCs at diabetogenic conditions can be reversed by Go6976. (A) Depicts
untreated MDA MB468 cells embedded in a 3D collagen matrix. As indicated by rim-1 staining, the PKC is localised in the cytosol, whereas Sytox green was
used for staining of the nucleii. Rim-1 staining of MDA MB468 cells stimulated with 11mM glucose and 100ngml
 1 insulin shows a translocation of PKC
towards the membrane and the pseudopodia – indicated by the arrows in (B), whereas the PKCa-specific inhibitor Go6976 (6nM) was able to diminish the
insulin-mediated translocation (C).
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Figure 5 (A) Immunoblot analysis of MLCK expression of breast cancer (MDA MB468) and colon carcinoma (SW480) cell lines. Antibodies against
the human myosin light chain kinase (MLCK) were used, and specifically bound antibodies were detected with the use of a secondary HRP-linked antibody.
The expression levels of all blots were evaluated using the Wasabi software version 1.4. (B) Inhibition of the pro-migratory effects of glucose and insulin in
SW480 cells by the MLCK-specific inhibitor ML-7. Migration of the cells was induced by incubating the cells with high glucose concentrations (11mM) and by
the addition of 100ngml
 1 insulin. Locomotory activity and therefore the distance migrated was blocked by the addition of 10mM ML-7. The graphs show
mean values of three independent experiments (90 cells were analysed per sample). *Po0.05; **Po0.01; ***Po0.001.
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periods of cell culture without the need to monitor glucose
concentration. However, these hyperglycemic conditions may lead
to changes in cellular functions, such as carbohydrate and fatty
acid metabolism, proliferation and cell motility.
Most of the aggressively growing tumours have common cellular
characteristics, including high proliferation rates and the potential
to invade peritumoural tissue. The increased proliferation and
concomitantly high metabolic activity is often accompanied by an
enhanced glycolysis and truncated mitochondrial respiration, also
known as the Warburg Effect (anaerobic glycolysis) (Gatenby and
Gillies, 2004). Those effects will be promoted by the above
mentioned culture media.
Additionally, aggressively growing tumours are often charac-
terized by an increased expression of GLUT-1 glucose transporters
(Hauptmann et al, 2005), resulting in a high glucose uptake, a
metabolic shift to anaerobe glycolysis and therefore an increased
lactate production (Gillies and Gatenby, 2007; Kroemer and
Pouyssegur, 2008). The tumour-associated Warburg effect has
been linked to a poorer clinical outcome of tumour patients
(Walenta and Mueller-Klieser, 2004; Kim and Dang, 2006). The
increased anaerobic metabolism of glucose is followed by an
elevated lactate secretion and acidification of the surrounding
tumour tissue (Pelicano et al, 2006). The acidification causes an
architectural deterioration of the ECM at the cutting edge of
tumour growth and thereby creating space for an exponentially
growing tumour mass. Furthermore, acidification may also lead to
increased activation of MMP activities (Chaussain-Miller et al,
2006).
Obesity is often associated with increased serum glucose and
triglycerides levels, as well as highly spiking insulin concentra-
tions, which are risk factors for increasing the likelihood of tumour
progression. Although the effects of obesity and high insulin as
promoters of cancer cell proliferation are described for colon
(Giovannucci, 2001), breast (Vona-Davis et al, 2007), endo-
metrium and kidney (Hjartaker et al, 2008), little is known
about the altered gene signatures with regard to cellular features
like cell adhesion and migration. Therefore, we cultured tumour
cell lines at physiological glucose concentrations (5.5mM) and
at high glucose (11mM) with or without additional insulin
(100ngml
 1). Thereafter, we analysed gene activities of transcripts
involved in cell cycle regulation, signal transduction, cell–cell
contacts and motor proteins as parts of the locomotory machinery,
comparing physiological and diabetogenic conditions.
At high insulin levels, we found higher number of transcripts of
genes responsible for cell cycle processes, such as cyclin A1 and E
regulation, the transition from G1 to S phase (see Table 1). Together
with the elevated copy numbers of transcription factor E2F, these
findings suggest increased proliferation rates as described for colon
cancer after insulin stimulation (Giovannucci, 2001).
Apart from the mode of action of insulin on the tumour cells
expressing insulin and IGF receptors, we found modulated gene
activities for cell cycle regulation, cell-to-cell contact and locomo-
tion when cells were cultured solely at high glucose (11mM).
These genetic findings suggest a diversity of insulin and
diabetogenic glucose concentrations modulating cell signalling
processes involved in proliferation and cell migration. Okumura
et al described increased PKCa levels when multi-drug resistant
MCF-7 cells were cultured in high glucose media (Okumura et al,
2002). They detected that an elevation of PKCa protein content
was followed by an increased content of DNA and elevated levels
of cyclin D. Although cyclin D can be found in oscillating
concentrations at almost all periods of the cell cycle, we found an
insulin and glucose-dependent upregulation of cyclins A and E
necessary for the transition from G1 to the S phase, which are more
pronounced markers for proliferation.
Furthermore, analysing migratory behaviour of SW480
and MDA MB468 cells, we have shown that high levels of
glucose-induced locomotory activity resulted in an extended
time of locomotion (caused by a reduced number and duration
of pauses), resulting in an elevated distance of migration.
When cells were stimulated with insulin the pro-migratory effects
were even stronger. These cell migration-promoting effects of
glucose and insulin were the result of altered gene activities
of several adhesion molecules (e.g. integrines and cadherins,
see Figure 1), and an increased PKCa activity (Figure 3) resulting
in an elevated activation of the locomotory machinery – namely
MLCK.
The activity of the migratory machinery – over-fueled by high
glucose (11mM) and insulin concentrations (100ngml
 1) – could
be reversed when the media were supplemented by the pharma-
cological PKCa-specific inhibitor Go6976 (6nM). These experi-
mental data indicate that high glucose concentrations are able
to induce PKCs – especially PKCa activity – functioning as
a propulsive cue to induce tumour cell locomotion (Figures 3B
and 4B).
Further clarifying the influence of PKCs at diabetogenic
conditions, we used a StressXpress PKC Kinase Activity Assay
Kit and found a strong activation of PKC enzymatic activities –
especially PKCa – as determined by the PKCa-specific inhibitor
Go6976 (3B). As both, the PKC enzymatic activity and the
migratory activity of the cells, were inhibited by Go6976, this
suggests that PKCa is activated at high glucose concentrations.
Downstream of the increased PKC activities within the locomotory
machinery, we also found elevated numbers of MLCK transcripts
(tab 1) as well as increased MLCK protein levels (Figure 5A).
The glucose- and insulin-promoted elevation of locomotion could
be completely blocked by the MLCK-specific inhibitor ML-7
(Figure 5B).
We found a downregulation of E-cadherin and an upregulation
of VE-cadherin at the transcriptional level as well as on the cell
surface. Low E-cadherin expressing tumour cells are more proned
to evade a tumour mass and to invade the surrounding tissue.
The increased levels of VE-cadherin on tumour cells with low
E-cadherin expression give the molecular advantages for extra-
vasation. This tumour evasion process is further stressed by the
upregulated collagen receptor (Table 1). Collagen is the main
component of the ECM and collagen fibers are mandatory
railroads for the locomotion of tumour and immune cells
(Entschladen et al, 2005). Under hyperglycemic conditions, we
observed not only an increased expression of the collagen receptor
but also of the integrin-linked kinase and other kinases, regulating
many cellular processes, including growth, proliferation, survival,
differentiation, migration, invasion and angiogenesis (McDonald
et al, 2008).
Hyperglycaemia and the Warburg effect lead to an
increased glucose metabolism, an elevated lactate production
and secretion, which cause the acidification of the tumour
microenvironment. The acidification induces cell death of non-
malignant tissues and thereby creating space for the growing
tumour mass. A further advantage to facilitate cellular motility
is the degradation of the ECM by the upregulation of metallo-
proteinase 7 and 10.
Our data strongly confirm a link between the epidemiological
observations and the molecular modulators of cell proliferation
and migration, how obesity and adiposity might influence the
clinical course of a cancer patient who also deals with DMT2. In
general, glucose has been seen as a food necessary for the supply
of fast energy in order to satisfy the cells’ demand on ATP. In
addition, our data indicate that glucose and insulin are directly
involved in cell signalling processes, responsible for the regulation
of proliferation and migration. Understanding the diverse roles of
glucose and insulin – energy supply and modulators of signalling
cascades – and delineating glucose and insulin signalling pathways
should facilitate prevention and drug discovery research to control
obesity, diabetes and cancer.
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